On August 2, 2017, researchers gathered at Emory University to conduct the official initiation visit for our upcoming Phase 1 study on the effect of MDMA on startle testing in healthy volunteers. This study is scheduled to begin screening subjects in mid-September and will be led by Principal Investigator Barbara Rothbaum, Ph.D., at Emory University. This study will be followed by another study exploring the combination of MDMA with Prolonged Exposure in PTSD patients. Learn more…
